Whitehawk Therapeutics, Inc. Common Stock WHWK Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $34.79M-7.4% | $37.57M-1.0% | $37.93M-73.8% | $144.94M-36.3% | $227.57M+694% | ||
| $88.25M-18.4% | $108.13M-13.3% | $124.67M+286% | $32.26M+824% | $3.49M-81.2% | ||
| $0— | $0-100% | $5.9M-52.6% | $12.44M-32.2% | $18.36M-21.2% | ||
| $0— | $0-100% | $5.31M-50.7% | $10.78M-36.1% | $16.88M-26.0% | ||
| $2.51M-24.5% | $3.32M+36.0% | $2.44M+65.8% | $1.47M-5.2% | $1.55M-45.3% | ||
| $125.55M-15.7% | $149.01M-9.7% | $165.04M-7.6% | $178.67M-23.2% | $232.61M+280% | ||
| $2K-33.3% | $3K-25.0% | $4K-55.6% | $9K-64.0% | $25K-99.6% | ||
| $1.68M-7.3% | $1.81M-8.2% | $1.98M-7.7% | $2.14M+57.2% | $1.36M-2.6% | ||
| $127.23M-15.6% | $150.83M-9.7% | $167.02M-7.6% | $180.82M-22.7% | $234M+233% | ||
| $1.75M+90.3% | $917K-43.8% | $1.63M-51.1% | $3.34M-8.7% | $3.66M+69.4% | ||
| $9.31M-31.5% | $13.6M+65.6% | $8.22M+51.7% | $5.42M-37.1% | $8.62M-41.2% | ||
| $11.06M-23.9% | $14.52M+47.4% | $9.85M+12.5% | $8.76M-28.7% | $12.27M-28.1% | ||
| $11.06M-23.9% | $14.52M+47.4% | $9.85M+12.5% | $8.76M-28.7% | $12.27M-31.2% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $4K0.0% | $4K0.0% | $4K0.0% | $4K-100.0% | $300M+14,999,900% | ||
| $491.63M+0.4% | $489.44M+0.5% | $487.02M+0.6% | $484.31M+0.6% | $481.36M+25.0% | ||
| -$375.44M-6.3% | -$353.25M-7.0% | -$330M-5.7% | -$312.25M-20.3% | -$259.64M+21.9% | ||
| -$15K-113% | $120K-13.7% | $139K+1,444% | $9K+800% | $1K-93.8% | ||
| $116.18M-14.8% | $136.31M-13.3% | $157.17M-8.7% | $172.07M-22.4% | $221.73M+323% | ||
| $127.23M-15.6% | $150.83M-9.7% | $167.02M-7.6% | $180.82M-22.7% | $234M+233% | ||
| $1.68M-7.3% | $1.81M-8.2% | $1.98M-7.7% | $2.14M+57.2% | $1.36M-2.6% | ||
| $1.68M-7.3% | $1.81M-8.2% | $1.98M-7.7% | $2.14M+57.2% | $1.36M-2.6% | ||
| $88.25M-18.4% | $108.13M-13.3% | $124.67M+286% | $32.26M+824% | $3.49M-81.2% | ||
| $1.68M-7.3% | $1.81M-8.2% | $1.98M-7.7% | $2.14M+57.2% | $1.36M-2.6% | ||
| $9.31M-31.5% | $13.6M+65.6% | $8.22M+51.7% | $5.42M-37.1% | $8.62M-41.2% | ||
| $9.31M-31.5% | $13.6M+65.6% | $8.22M+51.7% | $5.42M-37.1% | $8.62M-41.2% | ||
| $491.63M+0.4% | $489.44M+0.5% | $487.02M+0.6% | $484.31M+0.6% | $481.36M+25.0% | ||
| $4K0.0% | $4K0.0% | $4K0.0% | $4K0.0% | $4K+100% | ||
| $0— | $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Whitehawk Therapeutics, Inc. Common Stock's total assets?
- Whitehawk Therapeutics, Inc. Common Stock (WHWK) holds $127.2M in total assets, down 45.6% year over year.
- How much cash does Whitehawk Therapeutics, Inc. Common Stock have?
- Whitehawk Therapeutics, Inc. Common Stock holds $34.8M in cash and equivalents.
- Can Whitehawk Therapeutics, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 11.36 — current assets exceed current liabilities.
- Where does Whitehawk Therapeutics, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Whitehawk Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.